Some major asthma inhaler manufacturers announced $35 a month caps on out-of-pocket costs. The price cap will apply to people with commercial/private insurance (through your job or federal or state marketplace) or no insurance. If you have government-funded insurance (such as Medicare, Medicaid, or Tricare), you won’t qualify for a price cap, but you may qualify for a patient assistance program that can reduce what you pay. The inhalers that will be price capped include: AstraZeneca…
Quelle: Asthma and Allergy Foundation of America
Artikel: What You Need to Know About the $35 Price Cap on Asthma Inhalers
Titelbild/Grafik: Asthma and Allergy Foundation of America (AAFA)
Quick-Links
Aktuelles von Asthma and Allergy Foundation of America
- April Research Update: Asthma Clinical Trials, Insect Sting Allergy, Topical Steroid Withdrawal
- The CDC Asthma Program Is Gone
- March Research Update: Nasal Polyps, Chronic Hives, Dust Mite Allergy
- The Importance of Medicaid for People with Asthma and Allergies
- Recall Alert: Benadryl Liquid Elixir 100 mL Bottle
- 2025 Allergy Capitals™ Report: How Location and Climate Change Affect Your Seasonal Allergies
- Federal Support for People with Asthma and Allergies at Risk
- New Anaphylaxis Definition and Guidance for Treatment of Serious Allergic Reactions
- Spring Cleaning for an Asthma and Allergy Friendly Home
- Tree Pollen: Spring’s First Allergy Offender